An interventional study of CaCBT and Medication/ Psychotherapy in Depression, Anxiety, sponsored by Peshawar Medical College. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-08-16.
Sponsored by Peshawar Medical College · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 82 studies in Depression with a site in Pakistan — 23 open to participants now, 29 under way, none of them phase 3. Depression · Pakistan.
Among the 82 studies in Depression with a site in Pakistan, this one is the 67th largest by enrollment of the 77 interventional ones that give a count, is one of 3 that started in 2016, is one of 75 with no phase, and was the 10th registered.
8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.
Browse Depression studies →23 of the 82 studies in Depression with a site in Pakistan are open now. Recruiting first, the newest first:
Pakistan Institute of Living and Learning · Sites in Pakistan
Healthy volunteers
Khyber Medical University Peshawar · Sites in Pakistan
Ages 18+
Riphah International University · Sites in Pakistan
Healthy volunteers
Manahil Gill · Sites in Pakistan
Ages 18–55
Fazaia Ruth Pfau Medical College · Sites in Pakistan
Ages 18–45
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
82 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 3 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 40 is below the median of 81 across 7,089 interventional studies indexed under Depression.
Median enrollment 100 across the 77 interventional studies, 390 across the 5 observational. Of the 48 that completed or were terminated, 4 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 82 has an industry lead sponsor. The 10 most frequent:
Peshawar Medical College is the lead sponsor of 3 studies on the registry; none are open to participants now.
Peshawar Medical College has 2 studies filed under Depression — fewer than ten, so there is no comparison to draw.
5 of the studies in Depression with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07819448Manahil GillAerobic Exercise as an Adjunct Therapy for Depression | 2027-02-01 |
| NCT07722949Khyber Medical University PeshawarFeasibility of a Culturally Adapted Nurse-Led COPE Intervention for Caregivers of Children With Autism Spectrum Disorder | 2027-03-30 |
| NCT07654179Riphah International UniversityMetformin as Adjunct Therapy in Depression-obesity Comorbidity: Clinical and Genetic Evaluation | 2027-06-11 |
| NCT07790835Pakistan Institute of Living and LearningCultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents | 2027-09-30 |
| NCT07833982Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST) UniversityEfficacy of an Integrated Psychological Interventions Combined With Ar_Rahman Listening for Reducing Psychological Distress and Enhancing Hope and Quality of Life Among Cancer Patients: A Randomized Controlled Trial | 2027-11-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 82 studies in Depression with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
CBT for common mental disorders has a strong evidence base in both the USA and the UK. There are wider cultural and linguistic differences between Non Pashtun and Pashtun population of Pakistan and Afghanistan and there is evidence from research to suggest that CBT might need some adaptations when working with clients from non-western background. This study, thus, aims to culturally adapt CBT for common mental disorders for Pashto speaking population in Pakistan and Afghanistan and to test the effectiveness of this adapted CBT through a small scale pilot study.
The study will be carried out using mixed methods; quantitative and qualitative. Qualitative part will consist of structured interview with a minimum of 10-15 patients; carers; and mental health professionals, respectively, using the interview questionnaires. The data will be analysed by systematic content and question analysis which will identify the emerging themes and categories. The data will then be reorganized into wider themes and categories and written for guidelines to culturally adapt therapy manual for common mental disorders.
Quantitative phase will be a RCT involving 40 patients (20 in each arm) to assess the effectiveness of a "CaCBT intervention" for Pashto speaking patients. All those who fulfill the diagnostic criteria of depressive episode or recurrent depressive disorder using ICD 10 RDC, are living near or can easily travel to the psychiatry departments in Peshawar, will be included in the study.
The intervention group of the RCT will receive CaCBT intervention in addition to the treatment as usual (TAU) while the control group receives TAU. The assessment will be carried out at base-line and at the end of therapy (8-12 weeks). Bradford Somatic Inventory (BSI), Hospital Anxiety and Depression Scale (HADS) and Brief Disability Questionnaire (BDQ)/ WHO DAS will be used to measure somatic symptoms, anxiety, depression and disability due to physical and psychological problems, respectively. Schwartz Outcome Scale will be used at follow up to measure the outcome.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Receiving "CaCBT intervention" in addition to the Treatment as usual
Other: CaCBT · Other: Medication/ Psychotherapy
Receiving Treatment as usual
Other: Medication/ Psychotherapy
Culturally Adapted Cognitive Behaviour Therapy
Medication/ Psychotherapy used as usual
Change in score of Hospital Anxiety and Depression Scale (HADS) from baseline to end of therapy
At baseline and after end of therapy \[after 6 Weekly Sessions (in almost 8 weeks time)\]
Time frame: 2 Months
Change in score of Bradford Somatic Inventory (BSI) from baseline to end of therapy
At baseline and after end of therapy \[after 6 Weekly Sessions (in almost 8 weeks time)\]
Time frame: 2 Months
Change in score of Brief Disability Questionnaire/ WHO DAS from baseline to end of therapy
At baseline and after end of therapy \[after 6 Weekly Sessions (in almost 8 weeks time)\]
Time frame: 2 Months
Schwartz Outcome Scale
At end of therapy
Time frame: 2 Months
Plan to share: No
No publications or documents are linked to this record.
The record gives a start of Jan 2016, a primary completion of Jul 2016 and a completion of Jul 2016. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peshawar Medical College